The synergistic effect of combined IL-2 and IL-12 in promoting cytotoxic activity of NK cells through IFN-γ production, has been translated into a clinical therapeutic role for IL-12 in augmenting NK cytotoxity in cancer [74,75]. Here, IFNG is linked to cancer.